nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—PDE5A—artery—uterine cancer	0.0217	0.0635	CbGeAlD
Pentoxifylline—NT5E—myometrium—uterine cancer	0.0161	0.0473	CbGeAlD
Pentoxifylline—Caffeine—PIK3CA—uterine cancer	0.0157	1	CrCbGaD
Pentoxifylline—NT5E—epithelium—uterine cancer	0.0127	0.0371	CbGeAlD
Pentoxifylline—NT5E—uterine cervix—uterine cancer	0.0126	0.0368	CbGeAlD
Pentoxifylline—NT5E—smooth muscle tissue—uterine cancer	0.0122	0.0358	CbGeAlD
Pentoxifylline—NT5E—decidua—uterine cancer	0.012	0.0351	CbGeAlD
Pentoxifylline—NT5E—renal system—uterine cancer	0.0117	0.0344	CbGeAlD
Pentoxifylline—NT5E—endometrium—uterine cancer	0.0114	0.0333	CbGeAlD
Pentoxifylline—NT5E—mammalian vulva—uterine cancer	0.011	0.0322	CbGeAlD
Pentoxifylline—NT5E—uterus—uterine cancer	0.0105	0.0307	CbGeAlD
Pentoxifylline—ADORA2B—smooth muscle tissue—uterine cancer	0.0104	0.0306	CbGeAlD
Pentoxifylline—ADORA2B—decidua—uterine cancer	0.0102	0.03	CbGeAlD
Pentoxifylline—NT5E—female reproductive system—uterine cancer	0.00941	0.0276	CbGeAlD
Pentoxifylline—ADORA2B—mammalian vulva—uterine cancer	0.00941	0.0276	CbGeAlD
Pentoxifylline—PDE4A—decidua—uterine cancer	0.00913	0.0268	CbGeAlD
Pentoxifylline—NT5E—female gonad—uterine cancer	0.00856	0.0251	CbGeAlD
Pentoxifylline—NT5E—vagina—uterine cancer	0.00851	0.0249	CbGeAlD
Pentoxifylline—PDE5A—epithelium—uterine cancer	0.00822	0.0241	CbGeAlD
Pentoxifylline—PDE5A—uterine cervix—uterine cancer	0.00815	0.0239	CbGeAlD
Pentoxifylline—PDE5A—smooth muscle tissue—uterine cancer	0.00792	0.0232	CbGeAlD
Pentoxifylline—PDE5A—renal system—uterine cancer	0.00762	0.0223	CbGeAlD
Pentoxifylline—ADORA2B—vagina—uterine cancer	0.00729	0.0214	CbGeAlD
Pentoxifylline—ADORA1—renal system—uterine cancer	0.00723	0.0212	CbGeAlD
Pentoxifylline—ADORA2A—female reproductive system—uterine cancer	0.0067	0.0196	CbGeAlD
Pentoxifylline—PDE4A—female gonad—uterine cancer	0.00653	0.0192	CbGeAlD
Pentoxifylline—PDE5A—female reproductive system—uterine cancer	0.00611	0.0179	CbGeAlD
Pentoxifylline—ADORA1—female reproductive system—uterine cancer	0.00579	0.017	CbGeAlD
Pentoxifylline—PDE4B—uterine cervix—uterine cancer	0.00571	0.0167	CbGeAlD
Pentoxifylline—PDE5A—female gonad—uterine cancer	0.00556	0.0163	CbGeAlD
Pentoxifylline—PDE5A—vagina—uterine cancer	0.00552	0.0162	CbGeAlD
Pentoxifylline—NT5E—lymph node—uterine cancer	0.0055	0.0161	CbGeAlD
Pentoxifylline—PDE4B—decidua—uterine cancer	0.00544	0.016	CbGeAlD
Pentoxifylline—ADORA1—vagina—uterine cancer	0.00523	0.0153	CbGeAlD
Pentoxifylline—PDE4B—endometrium—uterine cancer	0.00517	0.0151	CbGeAlD
Pentoxifylline—PDE4B—mammalian vulva—uterine cancer	0.005	0.0147	CbGeAlD
Pentoxifylline—PDE4B—female reproductive system—uterine cancer	0.00428	0.0125	CbGeAlD
Pentoxifylline—PDE4A—lymph node—uterine cancer	0.0042	0.0123	CbGeAlD
Pentoxifylline—PDE4B—female gonad—uterine cancer	0.0039	0.0114	CbGeAlD
Pentoxifylline—PDE4B—vagina—uterine cancer	0.00387	0.0113	CbGeAlD
Pentoxifylline—PDE5A—lymph node—uterine cancer	0.00357	0.0105	CbGeAlD
Pentoxifylline—ADORA1—lymph node—uterine cancer	0.00339	0.00992	CbGeAlD
Pentoxifylline—CYP1A2—renal system—uterine cancer	0.00328	0.00962	CbGeAlD
Pentoxifylline—PDE4B—lymph node—uterine cancer	0.0025	0.00734	CbGeAlD
Pentoxifylline—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00154	0.0025	CcSEcCtD
Pentoxifylline—Jaundice—Etoposide—uterine cancer	0.00153	0.00248	CcSEcCtD
Pentoxifylline—Malaise—Dactinomycin—uterine cancer	0.00152	0.00248	CcSEcCtD
Pentoxifylline—Salivary hypersecretion—Epirubicin—uterine cancer	0.00152	0.00248	CcSEcCtD
Pentoxifylline—Influenza like illness—Epirubicin—uterine cancer	0.00152	0.00248	CcSEcCtD
Pentoxifylline—Leukopenia—Dactinomycin—uterine cancer	0.00151	0.00246	CcSEcCtD
Pentoxifylline—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00151	0.00246	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Etoposide—uterine cancer	0.00148	0.00241	CcSEcCtD
Pentoxifylline—Aplastic anaemia—Epirubicin—uterine cancer	0.00147	0.0024	CcSEcCtD
Pentoxifylline—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00146	0.00237	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00145	0.00235	CcSEcCtD
Pentoxifylline—Cramps of lower extremities—Epirubicin—uterine cancer	0.00144	0.00234	CcSEcCtD
Pentoxifylline—Myalgia—Dactinomycin—uterine cancer	0.00144	0.00234	CcSEcCtD
Pentoxifylline—Hypersensitivity—Progesterone—uterine cancer	0.00144	0.00234	CcSEcCtD
Pentoxifylline—Eructation—Doxorubicin—uterine cancer	0.00143	0.00232	CcSEcCtD
Pentoxifylline—Discomfort—Dactinomycin—uterine cancer	0.00142	0.00231	CcSEcCtD
Pentoxifylline—Influenza like illness—Doxorubicin—uterine cancer	0.00141	0.00229	CcSEcCtD
Pentoxifylline—Salivary hypersecretion—Doxorubicin—uterine cancer	0.00141	0.00229	CcSEcCtD
Pentoxifylline—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.0014	0.00229	CcSEcCtD
Pentoxifylline—Asthenia—Progesterone—uterine cancer	0.0014	0.00228	CcSEcCtD
Pentoxifylline—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.0014	0.00227	CcSEcCtD
Pentoxifylline—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.0014	0.00227	CcSEcCtD
Pentoxifylline—Pruritus—Progesterone—uterine cancer	0.00138	0.00225	CcSEcCtD
Pentoxifylline—Oedema—Dactinomycin—uterine cancer	0.00138	0.00224	CcSEcCtD
Pentoxifylline—Infection—Dactinomycin—uterine cancer	0.00137	0.00223	CcSEcCtD
Pentoxifylline—Aplastic anaemia—Doxorubicin—uterine cancer	0.00136	0.00222	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Dactinomycin—uterine cancer	0.00135	0.0022	CcSEcCtD
Pentoxifylline—Diarrhoea—Progesterone—uterine cancer	0.00133	0.00217	CcSEcCtD
Pentoxifylline—Cramps of lower extremities—Doxorubicin—uterine cancer	0.00133	0.00217	CcSEcCtD
Pentoxifylline—Anorexia—Dactinomycin—uterine cancer	0.00131	0.00214	CcSEcCtD
Pentoxifylline—Flushing—Etoposide—uterine cancer	0.0013	0.00212	CcSEcCtD
Pentoxifylline—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.0013	0.00212	CcSEcCtD
Pentoxifylline—Dizziness—Progesterone—uterine cancer	0.00129	0.0021	CcSEcCtD
Pentoxifylline—Vascular purpura—Epirubicin—uterine cancer	0.00127	0.00207	CcSEcCtD
Pentoxifylline—Immune system disorder—Etoposide—uterine cancer	0.00127	0.00207	CcSEcCtD
Pentoxifylline—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00127	0.00206	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00126	0.00204	CcSEcCtD
Pentoxifylline—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00125	0.00204	CcSEcCtD
Pentoxifylline—Vomiting—Progesterone—uterine cancer	0.00124	0.00202	CcSEcCtD
Pentoxifylline—Rash—Progesterone—uterine cancer	0.00123	0.002	CcSEcCtD
Pentoxifylline—Dermatitis—Progesterone—uterine cancer	0.00123	0.002	CcSEcCtD
Pentoxifylline—Headache—Progesterone—uterine cancer	0.00122	0.00199	CcSEcCtD
Pentoxifylline—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00121	0.00197	CcSEcCtD
Pentoxifylline—Decreased appetite—Dactinomycin—uterine cancer	0.0012	0.00195	CcSEcCtD
Pentoxifylline—Dysgeusia—Etoposide—uterine cancer	0.0012	0.00195	CcSEcCtD
Pentoxifylline—Back pain—Etoposide—uterine cancer	0.00118	0.00193	CcSEcCtD
Pentoxifylline—Purpura—Epirubicin—uterine cancer	0.00118	0.00192	CcSEcCtD
Pentoxifylline—Vascular purpura—Doxorubicin—uterine cancer	0.00118	0.00192	CcSEcCtD
Pentoxifylline—Anaphylactoid reaction—Epirubicin—uterine cancer	0.00118	0.00191	CcSEcCtD
Pentoxifylline—Muscle spasms—Etoposide—uterine cancer	0.00118	0.00191	CcSEcCtD
Pentoxifylline—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.0019	CcSEcCtD
Pentoxifylline—Nausea—Progesterone—uterine cancer	0.00116	0.00189	CcSEcCtD
Pentoxifylline—Feeling abnormal—Dactinomycin—uterine cancer	0.00114	0.00185	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Etoposide—uterine cancer	0.00113	0.00185	CcSEcCtD
Pentoxifylline—Anaemia—Etoposide—uterine cancer	0.00113	0.00184	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00113	0.00184	CcSEcCtD
Pentoxifylline—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.00183	CcSEcCtD
Pentoxifylline—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00111	0.00181	CcSEcCtD
Pentoxifylline—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00111	0.00181	CcSEcCtD
Pentoxifylline—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00111	0.0018	CcSEcCtD
Pentoxifylline—Malaise—Etoposide—uterine cancer	0.0011	0.00179	CcSEcCtD
Pentoxifylline—Leukopenia—Etoposide—uterine cancer	0.00109	0.00178	CcSEcCtD
Pentoxifylline—Purpura—Doxorubicin—uterine cancer	0.00109	0.00178	CcSEcCtD
Pentoxifylline—Abdominal pain—Dactinomycin—uterine cancer	0.00109	0.00177	CcSEcCtD
Pentoxifylline—Body temperature increased—Dactinomycin—uterine cancer	0.00109	0.00177	CcSEcCtD
Pentoxifylline—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.00109	0.00177	CcSEcCtD
Pentoxifylline—Convulsion—Etoposide—uterine cancer	0.00106	0.00172	CcSEcCtD
Pentoxifylline—Hypertension—Etoposide—uterine cancer	0.00106	0.00172	CcSEcCtD
Pentoxifylline—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00105	0.00171	CcSEcCtD
Pentoxifylline—Chest pain—Etoposide—uterine cancer	0.00104	0.00169	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00103	0.00168	CcSEcCtD
Pentoxifylline—Discomfort—Etoposide—uterine cancer	0.00103	0.00167	CcSEcCtD
Pentoxifylline—Hypersensitivity—Dactinomycin—uterine cancer	0.00102	0.00165	CcSEcCtD
Pentoxifylline—Confusional state—Etoposide—uterine cancer	0.00101	0.00164	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Etoposide—uterine cancer	0.000998	0.00162	CcSEcCtD
Pentoxifylline—Infection—Etoposide—uterine cancer	0.000991	0.00161	CcSEcCtD
Pentoxifylline—Abdominal distension—Epirubicin—uterine cancer	0.00099	0.00161	CcSEcCtD
Pentoxifylline—Asthenia—Dactinomycin—uterine cancer	0.000989	0.00161	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Etoposide—uterine cancer	0.000977	0.00159	CcSEcCtD
Pentoxifylline—Tachycardia—Etoposide—uterine cancer	0.000974	0.00159	CcSEcCtD
Pentoxifylline—Skin disorder—Etoposide—uterine cancer	0.000969	0.00158	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Etoposide—uterine cancer	0.000965	0.00157	CcSEcCtD
Pentoxifylline—Angina pectoris—Epirubicin—uterine cancer	0.000958	0.00156	CcSEcCtD
Pentoxifylline—Anorexia—Etoposide—uterine cancer	0.000951	0.00155	CcSEcCtD
Pentoxifylline—Diarrhoea—Dactinomycin—uterine cancer	0.000943	0.00154	CcSEcCtD
Pentoxifylline—Pancytopenia—Epirubicin—uterine cancer	0.000934	0.00152	CcSEcCtD
Pentoxifylline—Hypotension—Etoposide—uterine cancer	0.000933	0.00152	CcSEcCtD
Pentoxifylline—Abdominal distension—Doxorubicin—uterine cancer	0.000916	0.00149	CcSEcCtD
Pentoxifylline—Dyspnoea—Etoposide—uterine cancer	0.00089	0.00145	CcSEcCtD
Pentoxifylline—Somnolence—Etoposide—uterine cancer	0.000887	0.00144	CcSEcCtD
Pentoxifylline—Angina pectoris—Doxorubicin—uterine cancer	0.000887	0.00144	CcSEcCtD
Pentoxifylline—Infestation NOS—Epirubicin—uterine cancer	0.000877	0.00143	CcSEcCtD
Pentoxifylline—Infestation—Epirubicin—uterine cancer	0.000877	0.00143	CcSEcCtD
Pentoxifylline—Drowsiness—Epirubicin—uterine cancer	0.000877	0.00143	CcSEcCtD
Pentoxifylline—Vomiting—Dactinomycin—uterine cancer	0.000877	0.00143	CcSEcCtD
Pentoxifylline—Rash—Dactinomycin—uterine cancer	0.000869	0.00142	CcSEcCtD
Pentoxifylline—Decreased appetite—Etoposide—uterine cancer	0.000868	0.00141	CcSEcCtD
Pentoxifylline—Pancytopenia—Doxorubicin—uterine cancer	0.000864	0.00141	CcSEcCtD
Pentoxifylline—Jaundice—Epirubicin—uterine cancer	0.000855	0.00139	CcSEcCtD
Pentoxifylline—Constipation—Etoposide—uterine cancer	0.000853	0.00139	CcSEcCtD
Pentoxifylline—Conjunctivitis—Epirubicin—uterine cancer	0.000853	0.00139	CcSEcCtD
Pentoxifylline—Sweating—Epirubicin—uterine cancer	0.000841	0.00137	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Epirubicin—uterine cancer	0.00083	0.00135	CcSEcCtD
Pentoxifylline—Epistaxis—Epirubicin—uterine cancer	0.000827	0.00135	CcSEcCtD
Pentoxifylline—Feeling abnormal—Etoposide—uterine cancer	0.000822	0.00134	CcSEcCtD
Pentoxifylline—Nausea—Dactinomycin—uterine cancer	0.000819	0.00133	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Etoposide—uterine cancer	0.000816	0.00133	CcSEcCtD
Pentoxifylline—Infestation NOS—Doxorubicin—uterine cancer	0.000812	0.00132	CcSEcCtD
Pentoxifylline—Infestation—Doxorubicin—uterine cancer	0.000812	0.00132	CcSEcCtD
Pentoxifylline—Drowsiness—Doxorubicin—uterine cancer	0.000812	0.00132	CcSEcCtD
Pentoxifylline—Urticaria—Etoposide—uterine cancer	0.000793	0.00129	CcSEcCtD
Pentoxifylline—Haemoglobin—Epirubicin—uterine cancer	0.000791	0.00129	CcSEcCtD
Pentoxifylline—Jaundice—Doxorubicin—uterine cancer	0.000791	0.00129	CcSEcCtD
Pentoxifylline—Body temperature increased—Etoposide—uterine cancer	0.000789	0.00128	CcSEcCtD
Pentoxifylline—Abdominal pain—Etoposide—uterine cancer	0.000789	0.00128	CcSEcCtD
Pentoxifylline—Conjunctivitis—Doxorubicin—uterine cancer	0.000789	0.00128	CcSEcCtD
Pentoxifylline—Haemorrhage—Epirubicin—uterine cancer	0.000787	0.00128	CcSEcCtD
Pentoxifylline—Hepatitis—Epirubicin—uterine cancer	0.000787	0.00128	CcSEcCtD
Pentoxifylline—Sweating—Doxorubicin—uterine cancer	0.000778	0.00127	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000768	0.00125	CcSEcCtD
Pentoxifylline—Epistaxis—Doxorubicin—uterine cancer	0.000765	0.00125	CcSEcCtD
Pentoxifylline—Hypersensitivity—Etoposide—uterine cancer	0.000735	0.0012	CcSEcCtD
Pentoxifylline—Haemoglobin—Doxorubicin—uterine cancer	0.000732	0.00119	CcSEcCtD
Pentoxifylline—Flushing—Epirubicin—uterine cancer	0.000731	0.00119	CcSEcCtD
Pentoxifylline—Haemorrhage—Doxorubicin—uterine cancer	0.000729	0.00119	CcSEcCtD
Pentoxifylline—Hepatitis—Doxorubicin—uterine cancer	0.000729	0.00119	CcSEcCtD
Pentoxifylline—Asthenia—Etoposide—uterine cancer	0.000716	0.00117	CcSEcCtD
Pentoxifylline—Immune system disorder—Epirubicin—uterine cancer	0.000711	0.00116	CcSEcCtD
Pentoxifylline—Pruritus—Etoposide—uterine cancer	0.000706	0.00115	CcSEcCtD
Pentoxifylline—Arrhythmia—Epirubicin—uterine cancer	0.000703	0.00114	CcSEcCtD
Pentoxifylline—Erythema—Epirubicin—uterine cancer	0.000685	0.00112	CcSEcCtD
Pentoxifylline—Diarrhoea—Etoposide—uterine cancer	0.000683	0.00111	CcSEcCtD
Pentoxifylline—Flushing—Doxorubicin—uterine cancer	0.000676	0.0011	CcSEcCtD
Pentoxifylline—Flatulence—Epirubicin—uterine cancer	0.000675	0.0011	CcSEcCtD
Pentoxifylline—Tension—Epirubicin—uterine cancer	0.000673	0.00109	CcSEcCtD
Pentoxifylline—Dysgeusia—Epirubicin—uterine cancer	0.000671	0.00109	CcSEcCtD
Pentoxifylline—Nervousness—Epirubicin—uterine cancer	0.000666	0.00108	CcSEcCtD
Pentoxifylline—Back pain—Epirubicin—uterine cancer	0.000663	0.00108	CcSEcCtD
Pentoxifylline—Dizziness—Etoposide—uterine cancer	0.00066	0.00107	CcSEcCtD
Pentoxifylline—Muscle spasms—Epirubicin—uterine cancer	0.000659	0.00107	CcSEcCtD
Pentoxifylline—Immune system disorder—Doxorubicin—uterine cancer	0.000658	0.00107	CcSEcCtD
Pentoxifylline—Arrhythmia—Doxorubicin—uterine cancer	0.000651	0.00106	CcSEcCtD
Pentoxifylline—Vision blurred—Epirubicin—uterine cancer	0.000646	0.00105	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Epirubicin—uterine cancer	0.000636	0.00104	CcSEcCtD
Pentoxifylline—Vomiting—Etoposide—uterine cancer	0.000635	0.00103	CcSEcCtD
Pentoxifylline—Erythema—Doxorubicin—uterine cancer	0.000634	0.00103	CcSEcCtD
Pentoxifylline—Anaemia—Epirubicin—uterine cancer	0.000634	0.00103	CcSEcCtD
Pentoxifylline—Agitation—Epirubicin—uterine cancer	0.00063	0.00103	CcSEcCtD
Pentoxifylline—Rash—Etoposide—uterine cancer	0.000629	0.00102	CcSEcCtD
Pentoxifylline—Dermatitis—Etoposide—uterine cancer	0.000629	0.00102	CcSEcCtD
Pentoxifylline—Headache—Etoposide—uterine cancer	0.000625	0.00102	CcSEcCtD
Pentoxifylline—Flatulence—Doxorubicin—uterine cancer	0.000625	0.00102	CcSEcCtD
Pentoxifylline—Tension—Doxorubicin—uterine cancer	0.000622	0.00101	CcSEcCtD
Pentoxifylline—Dysgeusia—Doxorubicin—uterine cancer	0.000621	0.00101	CcSEcCtD
Pentoxifylline—Malaise—Epirubicin—uterine cancer	0.000618	0.00101	CcSEcCtD
Pentoxifylline—Nervousness—Doxorubicin—uterine cancer	0.000616	0.001	CcSEcCtD
Pentoxifylline—Leukopenia—Epirubicin—uterine cancer	0.000614	0.000999	CcSEcCtD
Pentoxifylline—Back pain—Doxorubicin—uterine cancer	0.000613	0.000999	CcSEcCtD
Pentoxifylline—Muscle spasms—Doxorubicin—uterine cancer	0.00061	0.000992	CcSEcCtD
Pentoxifylline—Palpitations—Epirubicin—uterine cancer	0.000606	0.000986	CcSEcCtD
Pentoxifylline—Vision blurred—Doxorubicin—uterine cancer	0.000598	0.000973	CcSEcCtD
Pentoxifylline—Convulsion—Epirubicin—uterine cancer	0.000594	0.000967	CcSEcCtD
Pentoxifylline—Nausea—Etoposide—uterine cancer	0.000593	0.000965	CcSEcCtD
Pentoxifylline—Hypertension—Epirubicin—uterine cancer	0.000592	0.000963	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Doxorubicin—uterine cancer	0.000588	0.000958	CcSEcCtD
Pentoxifylline—Anaemia—Doxorubicin—uterine cancer	0.000586	0.000954	CcSEcCtD
Pentoxifylline—Chest pain—Epirubicin—uterine cancer	0.000584	0.00095	CcSEcCtD
Pentoxifylline—Myalgia—Epirubicin—uterine cancer	0.000584	0.00095	CcSEcCtD
Pentoxifylline—Agitation—Doxorubicin—uterine cancer	0.000583	0.000949	CcSEcCtD
Pentoxifylline—Anxiety—Epirubicin—uterine cancer	0.000582	0.000947	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.00058	0.000943	CcSEcCtD
Pentoxifylline—Discomfort—Epirubicin—uterine cancer	0.000577	0.000938	CcSEcCtD
Pentoxifylline—Malaise—Doxorubicin—uterine cancer	0.000572	0.000931	CcSEcCtD
Pentoxifylline—Dry mouth—Epirubicin—uterine cancer	0.000571	0.000929	CcSEcCtD
Pentoxifylline—Leukopenia—Doxorubicin—uterine cancer	0.000568	0.000924	CcSEcCtD
Pentoxifylline—Confusional state—Epirubicin—uterine cancer	0.000564	0.000918	CcSEcCtD
Pentoxifylline—Palpitations—Doxorubicin—uterine cancer	0.00056	0.000912	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Epirubicin—uterine cancer	0.000559	0.000911	CcSEcCtD
Pentoxifylline—Oedema—Epirubicin—uterine cancer	0.000559	0.000911	CcSEcCtD
Pentoxifylline—Infection—Epirubicin—uterine cancer	0.000556	0.000905	CcSEcCtD
Pentoxifylline—Shock—Epirubicin—uterine cancer	0.00055	0.000896	CcSEcCtD
Pentoxifylline—Convulsion—Doxorubicin—uterine cancer	0.00055	0.000894	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Epirubicin—uterine cancer	0.000548	0.000892	CcSEcCtD
Pentoxifylline—Hypertension—Doxorubicin—uterine cancer	0.000548	0.000891	CcSEcCtD
Pentoxifylline—Tachycardia—Epirubicin—uterine cancer	0.000546	0.000889	CcSEcCtD
Pentoxifylline—Skin disorder—Epirubicin—uterine cancer	0.000543	0.000884	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Epirubicin—uterine cancer	0.000541	0.00088	CcSEcCtD
Pentoxifylline—Myalgia—Doxorubicin—uterine cancer	0.00054	0.000879	CcSEcCtD
Pentoxifylline—Chest pain—Doxorubicin—uterine cancer	0.00054	0.000879	CcSEcCtD
Pentoxifylline—Anxiety—Doxorubicin—uterine cancer	0.000538	0.000876	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000536	0.000873	CcSEcCtD
Pentoxifylline—Discomfort—Doxorubicin—uterine cancer	0.000533	0.000868	CcSEcCtD
Pentoxifylline—Anorexia—Epirubicin—uterine cancer	0.000533	0.000868	CcSEcCtD
Pentoxifylline—Dry mouth—Doxorubicin—uterine cancer	0.000528	0.00086	CcSEcCtD
Pentoxifylline—Hypotension—Epirubicin—uterine cancer	0.000523	0.000851	CcSEcCtD
Pentoxifylline—Confusional state—Doxorubicin—uterine cancer	0.000522	0.00085	CcSEcCtD
Pentoxifylline—Oedema—Doxorubicin—uterine cancer	0.000518	0.000843	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Doxorubicin—uterine cancer	0.000518	0.000843	CcSEcCtD
Pentoxifylline—Infection—Doxorubicin—uterine cancer	0.000514	0.000837	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.00051	0.00083	CcSEcCtD
Pentoxifylline—Shock—Doxorubicin—uterine cancer	0.000509	0.000829	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Doxorubicin—uterine cancer	0.000507	0.000825	CcSEcCtD
Pentoxifylline—Insomnia—Epirubicin—uterine cancer	0.000506	0.000824	CcSEcCtD
Pentoxifylline—Tachycardia—Doxorubicin—uterine cancer	0.000505	0.000822	CcSEcCtD
Pentoxifylline—Skin disorder—Doxorubicin—uterine cancer	0.000503	0.000818	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Doxorubicin—uterine cancer	0.0005	0.000814	CcSEcCtD
Pentoxifylline—Dyspnoea—Epirubicin—uterine cancer	0.000499	0.000812	CcSEcCtD
Pentoxifylline—Somnolence—Epirubicin—uterine cancer	0.000497	0.000809	CcSEcCtD
Pentoxifylline—Anorexia—Doxorubicin—uterine cancer	0.000493	0.000803	CcSEcCtD
Pentoxifylline—Dyspepsia—Epirubicin—uterine cancer	0.000492	0.000802	CcSEcCtD
Pentoxifylline—Decreased appetite—Epirubicin—uterine cancer	0.000486	0.000792	CcSEcCtD
Pentoxifylline—Hypotension—Doxorubicin—uterine cancer	0.000484	0.000787	CcSEcCtD
Pentoxifylline—Constipation—Epirubicin—uterine cancer	0.000478	0.000779	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000472	0.000768	CcSEcCtD
Pentoxifylline—Insomnia—Doxorubicin—uterine cancer	0.000468	0.000762	CcSEcCtD
Pentoxifylline—Dyspnoea—Doxorubicin—uterine cancer	0.000461	0.000751	CcSEcCtD
Pentoxifylline—Feeling abnormal—Epirubicin—uterine cancer	0.000461	0.00075	CcSEcCtD
Pentoxifylline—Somnolence—Doxorubicin—uterine cancer	0.00046	0.000749	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Epirubicin—uterine cancer	0.000457	0.000745	CcSEcCtD
Pentoxifylline—Dyspepsia—Doxorubicin—uterine cancer	0.000456	0.000742	CcSEcCtD
Pentoxifylline—Decreased appetite—Doxorubicin—uterine cancer	0.00045	0.000732	CcSEcCtD
Pentoxifylline—Urticaria—Epirubicin—uterine cancer	0.000444	0.000723	CcSEcCtD
Pentoxifylline—Constipation—Doxorubicin—uterine cancer	0.000443	0.00072	CcSEcCtD
Pentoxifylline—Abdominal pain—Epirubicin—uterine cancer	0.000442	0.00072	CcSEcCtD
Pentoxifylline—Body temperature increased—Epirubicin—uterine cancer	0.000442	0.00072	CcSEcCtD
Pentoxifylline—Feeling abnormal—Doxorubicin—uterine cancer	0.000427	0.000694	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000423	0.000689	CcSEcCtD
Pentoxifylline—Hypersensitivity—Epirubicin—uterine cancer	0.000412	0.000671	CcSEcCtD
Pentoxifylline—Urticaria—Doxorubicin—uterine cancer	0.000411	0.000669	CcSEcCtD
Pentoxifylline—Body temperature increased—Doxorubicin—uterine cancer	0.000409	0.000666	CcSEcCtD
Pentoxifylline—Abdominal pain—Doxorubicin—uterine cancer	0.000409	0.000666	CcSEcCtD
Pentoxifylline—Asthenia—Epirubicin—uterine cancer	0.000401	0.000653	CcSEcCtD
Pentoxifylline—Pruritus—Epirubicin—uterine cancer	0.000396	0.000644	CcSEcCtD
Pentoxifylline—Diarrhoea—Epirubicin—uterine cancer	0.000383	0.000623	CcSEcCtD
Pentoxifylline—Hypersensitivity—Doxorubicin—uterine cancer	0.000381	0.000621	CcSEcCtD
Pentoxifylline—Asthenia—Doxorubicin—uterine cancer	0.000371	0.000604	CcSEcCtD
Pentoxifylline—Dizziness—Epirubicin—uterine cancer	0.00037	0.000602	CcSEcCtD
Pentoxifylline—Pruritus—Doxorubicin—uterine cancer	0.000366	0.000596	CcSEcCtD
Pentoxifylline—Vomiting—Epirubicin—uterine cancer	0.000356	0.000579	CcSEcCtD
Pentoxifylline—Diarrhoea—Doxorubicin—uterine cancer	0.000354	0.000576	CcSEcCtD
Pentoxifylline—Rash—Epirubicin—uterine cancer	0.000353	0.000574	CcSEcCtD
Pentoxifylline—Dermatitis—Epirubicin—uterine cancer	0.000352	0.000574	CcSEcCtD
Pentoxifylline—Headache—Epirubicin—uterine cancer	0.00035	0.00057	CcSEcCtD
Pentoxifylline—Dizziness—Doxorubicin—uterine cancer	0.000342	0.000557	CcSEcCtD
Pentoxifylline—Nausea—Epirubicin—uterine cancer	0.000332	0.000541	CcSEcCtD
Pentoxifylline—Vomiting—Doxorubicin—uterine cancer	0.000329	0.000536	CcSEcCtD
Pentoxifylline—Rash—Doxorubicin—uterine cancer	0.000326	0.000531	CcSEcCtD
Pentoxifylline—Dermatitis—Doxorubicin—uterine cancer	0.000326	0.000531	CcSEcCtD
Pentoxifylline—Headache—Doxorubicin—uterine cancer	0.000324	0.000528	CcSEcCtD
Pentoxifylline—Nausea—Doxorubicin—uterine cancer	0.000307	0.0005	CcSEcCtD
Pentoxifylline—ADORA2A—Circadian rythm related genes—EP300—uterine cancer	6.99e-05	0.00243	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metapathway biotransformation—AKR1C3—uterine cancer	6.97e-05	0.00242	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—AKR1B10—uterine cancer	6.94e-05	0.00241	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—INHBA—uterine cancer	6.81e-05	0.00237	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—INHBA—uterine cancer	6.73e-05	0.00234	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	6.65e-05	0.00231	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—CXCL8—uterine cancer	6.63e-05	0.0023	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—AKR1C1—uterine cancer	6.55e-05	0.00228	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—ERBB2—uterine cancer	6.48e-05	0.00225	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—TP53—uterine cancer	6.48e-05	0.00225	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—NRAS—uterine cancer	6.41e-05	0.00223	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	6.31e-05	0.00219	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	6.31e-05	0.00219	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—KRAS—uterine cancer	6.14e-05	0.00213	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—AKR1C1—uterine cancer	6.13e-05	0.00213	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—AKR1C1—uterine cancer	6.06e-05	0.00211	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—CDKN1B—uterine cancer	6e-05	0.00209	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	5.97e-05	0.00208	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	5.9e-05	0.00205	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—RNF43—uterine cancer	5.75e-05	0.002	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—uterine cancer	5.72e-05	0.00199	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—CXCL8—uterine cancer	5.64e-05	0.00196	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—PIK3CA—uterine cancer	5.64e-05	0.00196	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—AKR1C3—uterine cancer	5.55e-05	0.00193	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—PTEN—uterine cancer	5.52e-05	0.00192	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—KRAS—uterine cancer	5.52e-05	0.00192	CbGpPWpGaD
Pentoxifylline—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	5.51e-05	0.00191	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—CCL2—uterine cancer	5.51e-05	0.00191	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—TP53—uterine cancer	5.45e-05	0.0019	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	5.43e-05	0.00189	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PGR—uterine cancer	5.41e-05	0.00188	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—INHBA—uterine cancer	5.26e-05	0.00183	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—HRAS—uterine cancer	5.22e-05	0.00181	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—YWHAE—uterine cancer	5.16e-05	0.00179	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	5.08e-05	0.00177	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—PIK3CA—uterine cancer	5.07e-05	0.00176	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—AKR1C3—uterine cancer	5.04e-05	0.00175	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—TP53—uterine cancer	5e-05	0.00174	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—FBXW7—uterine cancer	4.95e-05	0.00172	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—NRAS—uterine cancer	4.93e-05	0.00171	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PGR—uterine cancer	4.91e-05	0.00171	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	4.81e-05	0.00167	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	4.81e-05	0.00167	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—AKR1C1—uterine cancer	4.73e-05	0.00164	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—AKR1C3—uterine cancer	4.72e-05	0.00164	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—HRAS—uterine cancer	4.69e-05	0.00163	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—YWHAE—uterine cancer	4.69e-05	0.00163	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—AKR1C3—uterine cancer	4.66e-05	0.00162	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—AKT1—uterine cancer	4.61e-05	0.0016	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PGR—uterine cancer	4.6e-05	0.0016	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PGR—uterine cancer	4.54e-05	0.00158	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—FBXW7—uterine cancer	4.49e-05	0.00156	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—YWHAE—uterine cancer	4.39e-05	0.00152	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—CXCL8—uterine cancer	4.35e-05	0.00151	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—YWHAE—uterine cancer	4.34e-05	0.00151	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—STK11—uterine cancer	4.32e-05	0.0015	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	4.32e-05	0.0015	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—CCL2—uterine cancer	4.3e-05	0.0015	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—PTEN—uterine cancer	4.27e-05	0.00149	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—KRAS—uterine cancer	4.24e-05	0.00147	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—FBXW7—uterine cancer	4.21e-05	0.00146	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—FBXW7—uterine cancer	4.16e-05	0.00144	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—AKT1—uterine cancer	4.14e-05	0.00144	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—EP300—uterine cancer	4.08e-05	0.00142	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—SOCS3—uterine cancer	4.05e-05	0.00141	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—STK11—uterine cancer	3.93e-05	0.00136	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—CCL2—uterine cancer	3.91e-05	0.00136	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—PIK3CA—uterine cancer	3.9e-05	0.00135	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CDKN2B—uterine cancer	3.88e-05	0.00135	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IGF1R—uterine cancer	3.76e-05	0.00131	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—CXCL8—uterine cancer	3.75e-05	0.0013	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—SOCS3—uterine cancer	3.68e-05	0.00128	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—STK11—uterine cancer	3.68e-05	0.00128	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—CCL2—uterine cancer	3.66e-05	0.00127	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—AKR1C3—uterine cancer	3.64e-05	0.00127	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—STK11—uterine cancer	3.63e-05	0.00126	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—CCL2—uterine cancer	3.62e-05	0.00126	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—HRAS—uterine cancer	3.61e-05	0.00125	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PGR—uterine cancer	3.55e-05	0.00123	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—SMAD3—uterine cancer	3.54e-05	0.00123	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.53e-05	0.00123	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CDKN2B—uterine cancer	3.52e-05	0.00122	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—SOCS3—uterine cancer	3.44e-05	0.0012	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IGF1R—uterine cancer	3.42e-05	0.00119	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—CXCL8—uterine cancer	3.4e-05	0.00118	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—CXCL8—uterine cancer	3.4e-05	0.00118	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—SOCS3—uterine cancer	3.4e-05	0.00118	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—YWHAE—uterine cancer	3.39e-05	0.00118	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—FGFR2—uterine cancer	3.38e-05	0.00117	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CDKN2B—uterine cancer	3.3e-05	0.00115	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CDKN2B—uterine cancer	3.26e-05	0.00113	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—FBXW7—uterine cancer	3.25e-05	0.00113	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—SMAD3—uterine cancer	3.21e-05	0.00112	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IGF1R—uterine cancer	3.2e-05	0.00111	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—CXCL8—uterine cancer	3.19e-05	0.00111	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—AKT1—uterine cancer	3.18e-05	0.00111	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IGF1R—uterine cancer	3.16e-05	0.0011	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—CXCL8—uterine cancer	3.15e-05	0.00109	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—CXCL8—uterine cancer	3.09e-05	0.00107	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—FGFR2—uterine cancer	3.06e-05	0.00107	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—PIK3CA—uterine cancer	3.02e-05	0.00105	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—SMAD3—uterine cancer	3.01e-05	0.00105	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—SMAD3—uterine cancer	2.97e-05	0.00103	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—NDUFB11—uterine cancer	2.96e-05	0.00103	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—SRD5A2—uterine cancer	2.96e-05	0.00103	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—CXCL8—uterine cancer	2.89e-05	0.00101	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—ESR1—uterine cancer	2.89e-05	0.001	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.88e-05	0.000999	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—FGFR2—uterine cancer	2.87e-05	0.000997	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—CXCL8—uterine cancer	2.86e-05	0.000994	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—STK11—uterine cancer	2.84e-05	0.000987	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—FGFR2—uterine cancer	2.84e-05	0.000986	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CCL2—uterine cancer	2.83e-05	0.000982	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—NRAS—uterine cancer	2.73e-05	0.000949	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.72e-05	0.000944	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SOCS3—uterine cancer	2.66e-05	0.000924	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ESR1—uterine cancer	2.62e-05	0.000911	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CDKN2B—uterine cancer	2.54e-05	0.000884	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CCL2—uterine cancer	2.54e-05	0.000884	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—NRAS—uterine cancer	2.48e-05	0.000861	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IGF1R—uterine cancer	2.47e-05	0.000859	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—AKT1—uterine cancer	2.46e-05	0.000856	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—CXCL8—uterine cancer	2.46e-05	0.000855	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ESR1—uterine cancer	2.46e-05	0.000853	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ESR1—uterine cancer	2.43e-05	0.000843	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—PIK3CA—uterine cancer	2.38e-05	0.000826	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—KRAS—uterine cancer	2.35e-05	0.000817	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SMAD3—uterine cancer	2.32e-05	0.000807	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—NRAS—uterine cancer	2.32e-05	0.000807	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCL2—uterine cancer	2.31e-05	0.000802	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—NRAS—uterine cancer	2.29e-05	0.000797	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CXCL8—uterine cancer	2.23e-05	0.000776	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—FGFR2—uterine cancer	2.22e-05	0.00077	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CCL2—uterine cancer	2.16e-05	0.000751	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—PIK3CA—uterine cancer	2.16e-05	0.00075	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—PIK3CA—uterine cancer	2.16e-05	0.00075	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—AKR1B1—uterine cancer	2.14e-05	0.000744	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—STAR—uterine cancer	2.14e-05	0.000744	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CCL2—uterine cancer	2.14e-05	0.000742	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—KRAS—uterine cancer	2.13e-05	0.000741	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—ERBB2—uterine cancer	2.12e-05	0.000737	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.12e-05	0.000735	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—PIK3CA—uterine cancer	2.02e-05	0.000702	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CXCL8—uterine cancer	2.01e-05	0.000699	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—KRAS—uterine cancer	2e-05	0.000694	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—PIK3CA—uterine cancer	2e-05	0.000694	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—HRAS—uterine cancer	2e-05	0.000694	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—KRAS—uterine cancer	1.97e-05	0.000686	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CDKN1B—uterine cancer	1.96e-05	0.000682	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—PIK3CA—uterine cancer	1.96e-05	0.000681	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—AKT1—uterine cancer	1.94e-05	0.000675	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ERBB2—uterine cancer	1.92e-05	0.000669	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ESR1—uterine cancer	1.9e-05	0.000659	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CTNNB1—uterine cancer	1.85e-05	0.000645	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—PIK3CA—uterine cancer	1.84e-05	0.000638	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CXCL8—uterine cancer	1.83e-05	0.000634	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—PIK3CA—uterine cancer	1.81e-05	0.00063	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—HRAS—uterine cancer	1.81e-05	0.00063	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PTEN—uterine cancer	1.81e-05	0.000628	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ERBB2—uterine cancer	1.8e-05	0.000626	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—NRAS—uterine cancer	1.79e-05	0.000623	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CDKN1B—uterine cancer	1.78e-05	0.00062	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ERBB2—uterine cancer	1.78e-05	0.000619	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—AKT1—uterine cancer	1.76e-05	0.000613	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—AKT1—uterine cancer	1.76e-05	0.000613	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—EP300—uterine cancer	1.72e-05	0.000599	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CXCL8—uterine cancer	1.71e-05	0.000594	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—HRAS—uterine cancer	1.7e-05	0.00059	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CXCL8—uterine cancer	1.69e-05	0.000587	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CTNNB1—uterine cancer	1.68e-05	0.000585	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—POLD1—uterine cancer	1.68e-05	0.000584	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—HRAS—uterine cancer	1.68e-05	0.000583	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCL2—uterine cancer	1.67e-05	0.00058	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CDKN1B—uterine cancer	1.67e-05	0.00058	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—AKT1—uterine cancer	1.65e-05	0.000574	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CDKN1B—uterine cancer	1.65e-05	0.000573	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PTEN—uterine cancer	1.64e-05	0.00057	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—VEGFA—uterine cancer	1.63e-05	0.000567	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—AKT1—uterine cancer	1.63e-05	0.000567	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NRAS—uterine cancer	1.61e-05	0.00056	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—AKT1—uterine cancer	1.6e-05	0.000556	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CTNNB1—uterine cancer	1.58e-05	0.000548	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—AKR1C1—uterine cancer	1.57e-05	0.000546	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—EP300—uterine cancer	1.57e-05	0.000544	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—PIK3CA—uterine cancer	1.56e-05	0.000542	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CTNNB1—uterine cancer	1.56e-05	0.000542	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—KRAS—uterine cancer	1.54e-05	0.000536	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PTEN—uterine cancer	1.54e-05	0.000534	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PTEN—uterine cancer	1.52e-05	0.000528	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—AKT1—uterine cancer	1.5e-05	0.000521	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—VEGFA—uterine cancer	1.48e-05	0.000515	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—AKT1—uterine cancer	1.48e-05	0.000515	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—EP300—uterine cancer	1.47e-05	0.000509	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NRAS—uterine cancer	1.46e-05	0.000509	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—EP300—uterine cancer	1.45e-05	0.000503	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—PIK3CA—uterine cancer	1.42e-05	0.000493	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—RRM2—uterine cancer	1.4e-05	0.000487	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ERBB2—uterine cancer	1.39e-05	0.000484	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—VEGFA—uterine cancer	1.39e-05	0.000482	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—KRAS—uterine cancer	1.39e-05	0.000482	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—VEGFA—uterine cancer	1.37e-05	0.000477	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NRAS—uterine cancer	1.37e-05	0.000477	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—DCN—uterine cancer	1.36e-05	0.000472	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NRAS—uterine cancer	1.35e-05	0.000471	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CXCL8—uterine cancer	1.32e-05	0.000459	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—HRAS—uterine cancer	1.31e-05	0.000456	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CDKN1B—uterine cancer	1.29e-05	0.000448	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP11A1—uterine cancer	1.28e-05	0.000445	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PIK3CA—uterine cancer	1.28e-05	0.000443	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—AKT1—uterine cancer	1.27e-05	0.000443	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—KRAS—uterine cancer	1.26e-05	0.000438	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TP53—uterine cancer	1.23e-05	0.000429	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CTNNB1—uterine cancer	1.22e-05	0.000423	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—AKR1C3—uterine cancer	1.21e-05	0.00042	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PTEN—uterine cancer	1.19e-05	0.000412	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—KRAS—uterine cancer	1.18e-05	0.00041	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HRAS—uterine cancer	1.18e-05	0.00041	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—KRAS—uterine cancer	1.17e-05	0.000405	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PIK3CA—uterine cancer	1.16e-05	0.000402	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—AKT1—uterine cancer	1.16e-05	0.000402	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—EP300—uterine cancer	1.13e-05	0.000393	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TP53—uterine cancer	1.12e-05	0.000389	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PIK3CA—uterine cancer	1.08e-05	0.000377	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—VEGFA—uterine cancer	1.07e-05	0.000372	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PIK3CA—uterine cancer	1.07e-05	0.000372	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HRAS—uterine cancer	1.07e-05	0.000372	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NRAS—uterine cancer	1.06e-05	0.000368	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TP53—uterine cancer	1.05e-05	0.000365	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—AKT1—uterine cancer	1.04e-05	0.000362	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TP53—uterine cancer	1.04e-05	0.00036	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HRAS—uterine cancer	1e-05	0.000349	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HRAS—uterine cancer	9.91e-06	0.000344	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—AKT1—uterine cancer	9.46e-06	0.000329	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP19A1—uterine cancer	9.42e-06	0.000327	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—STK11—uterine cancer	9.42e-06	0.000327	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—KRAS—uterine cancer	9.11e-06	0.000317	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—AKT1—uterine cancer	8.86e-06	0.000308	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.84e-06	0.000307	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—AKT1—uterine cancer	8.75e-06	0.000304	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	8.43e-06	0.000293	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PIK3CA—uterine cancer	8.37e-06	0.000291	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TP53—uterine cancer	8.1e-06	0.000281	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HRAS—uterine cancer	7.75e-06	0.000269	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—MTHFR—uterine cancer	7.08e-06	0.000246	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—AKT1—uterine cancer	6.84e-06	0.000238	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.24e-06	0.000217	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PTEN—uterine cancer	3.94e-06	0.000137	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—EP300—uterine cancer	3.76e-06	0.000131	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PIK3CA—uterine cancer	2.78e-06	9.66e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—AKT1—uterine cancer	2.27e-06	7.89e-05	CbGpPWpGaD
